• News
  • SAN DIEGO
  • Medical

Quidel gains FDA approval for strep test

Quidel Corp. (Nasdaq: QDEL), a San Diego-based provider of rapid diagnostic testing solutions, reports it has received clearance from the Food and Drug Administration (FDA) to market its Lyra Direct Strep Assay.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Quidel Corp.

Company Website

10165 McKellar Ct.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
QDEL
26.51
  -0.36  
- 1.34%
167,595,000
32.24
19.21

Insider Trade Data

Date Insider Shares Type Value
09/18/2014 Tamerius, John D 10,000 Exchange $85,000
09/18/2014 Tamerius, John D 10,000 Sell $265,000
09/18/2014 Tamerius, John D 10,000 Exchange $85,000
09/18/2014 Tamerius, John D 10,000 Sell $265,000
09/18/2014 Tamerius, John D 10,000 Sell $265,000

Quidel Corp. Executive(s):

Douglas Bryant

  • Chief Executive Officer, President

Randall Steward

  • Chief Financial Officer

Similar Companies

NAICS - 325413 - In-Vitro Diagnostic Substance Manufacturing
SIC - 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
Subscribe Today!